New drug approved in Europe for uncon... - Lung Conditions C...

Lung Conditions Community Forum

56,244 members66,867 posts

New drug approved in Europe for uncontrolled COPD.

PaulineHM profile image
24 Replies

Good news folks!

I learnt today that there is a new drug out for uncontrolled COPD with evidence type 2 inflammation levels.

This medication is called Dupixent and has been approved for use in Europe by the European Medicines Agency. Before you get too excited, of course this doesn't mean that it has been approved for use in the UK yet! It won't be available for everyone either when it is.

So watch this space people who have difficult to control COPD. Anything which will help to better manage the condition will undoubtedly be really welcome. If I hear any more then will post it up.

Quote from the pharmceutical company Sanofi. Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD

* First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life

* Dupixent is the first new treatment approach for COPD in more than a decade and a new option for approximately 220,000 adults in the EU

* Approval represents the sixth approved indication for Dupixent in the EU and seventh approved indication globally

Go well.

Pauline

Written by
PaulineHM profile image
PaulineHM
To view profiles and participate in discussions please or .
Read more about...
24 Replies
beech profile image
beech

Thanks for the information. I’ll be keeping a watch for more information 👍

Alberta56 profile image
Alberta56

That sounds good. Bring it on.

_9carole profile image
_9carole

Good news for us!! Yes please keep us informed.

Younie profile image
Younie

This drug is already in use in the UK for severe asthma and severe eczema, im on it for asthma, so hopefully that makes the availability of it for copd quicker than normal.

PaulineHM profile image
PaulineHM in reply toYounie

Oh right, thanks for that. I wonder then if that is the case then it will be easier to get approval for use in patients with COPD ?

Go well.

Pauline

pepparuby1 profile image
pepparuby1

I looked it up it’s already available see what I read

Bottom Line

Dupixent is approved for use in moderate-to-severe eczema (atopic dermatitis), in moderate-to-severe asthma, in patients with chronic rhinosinusitis (sinus and nasal cavity swelling) and nasal polyps (growths on the sinuses), in eosinophilic esophagitis (EoE), and for prurigo nodularis (a skin condition).

It is an injectable interleukin-4 receptor (IL-4) alpha antagonist that blocks receptors in the body to help lower inflammation that can lead to symptoms.

PaulineHM profile image
PaulineHM in reply topepparuby1

Yes I understand it is. It will need approval by NICE I imagine for use with the targeted COPD patients.

NICE approve for England and the devolved governments take their leads from that - as I understand it.

Watch this space huh?

Go well

Pauline

pepparuby1 profile image
pepparuby1 in reply toPaulineHM

Thank you for sharing Pauline. Funny I did a copd trial 19month ago that was an injection once a month - I got the placebo sadly - doubt it would be this but anything to help us is great

PaulineHM profile image
PaulineHM in reply topepparuby1

Oh that is interesting that you were on the trial.. yes, shame you got the placebo, but come the day when it is more available who knows you make be fortunate to be offered it ?

Go well,

Pauline

Coughingalltheway profile image
Coughingalltheway

Good news but also a little confusing to me. My respriatory team and the consultant both told me that raised blood eosinophils was a marker for asthma, not COPD unless the drug is for overlap patients with both conditions?

PaulineHM profile image
PaulineHM in reply toCoughingalltheway

Hmmmm, not sure that is exactly always the case, though it may be for some.

There is a move to try and bring forward novel pharmaceuticals for better targeted treatment.

Don’t know of this article helps ?

thorax.bmj.com/content/76/2...

Go well.

Pauline

Coughingalltheway profile image
Coughingalltheway in reply toPaulineHM

Thanks Pauline, interesting article.

I pulled this exert from the European Medical Journal but the article was dated 2015 so maybe there is newer evidence now:

On comparing the eosinophil counts of the three groups, we found that the asthma group had significantly higher values than those of the COPD and ACO groups but when we compared the neutrophil counts, we found an opposite trend in the results. The neutrophil counts in the COPD and ACO groups were significantly higher than those in the asthma group.

Thanks for posting the BMJ article, I'm a firm believer in gaining as much knowledge as possible.

Take care

Jan xx

PaulineHM profile image
PaulineHM in reply toCoughingalltheway

Thanks for this Jan, very interesting and useful information. This certainly equates with my experience !

Hoping for many that this medication will be available for people with ACOS ( who might benefit ) soon.

Go well,

Pauline

Coughingalltheway profile image
Coughingalltheway in reply toPaulineHM

I believe that they think that I've got ACOS, just waiting for the final confirmation. 🤞that the new meds will be available soon.

Take care

Jan xx

PaulineHM profile image
PaulineHM in reply toCoughingalltheway

Hi Jan, look after yourself. Xx

Rich1957 profile image
Rich1957

It will become available hopefully in November for COPD sufferers with raised blood eosinophil levels .

I have a letter from my consultants saying I’ll be put on it in November as I’ve been on previous Trials with this drug and another , which totally changed my life while I was taking it . I never had one chest infection and obviously no hospital stays 😊😊

PaulineHM profile image
PaulineHM in reply toRich1957

Hi Rich, oh that is interesting, thanks for letting us know that. I have both Asthma and COPD but not currently under consultant care.

I have been taking Roflumilast for the last two years and it has changed my life too. No bacterial or other chest infections since I started taking it. Such a feeling of well-being too! What a relief.

Keep in touch won’t you and let us know how you get on once it is prescribed for you.

Go well,

Pauline

clematis5932 profile image
clematis5932 in reply toPaulineHM

We have spoken before Pauline about Roflumilast I am still on it but have to say my acerbations have shown no improvement. Side effects are still ongoing for me. I shall stick with it for a while yet as I feel very lucky that I was offered it.

PaulineHM profile image
PaulineHM in reply toclematis5932

Hello again, Ah I hope that you might feel the benefit of the Roflumilast before too much more time goes by. Are you feeling disappointed ?

Looking back I recall the side effects lasting for the first 3-4 months before they settled down to none. I do still get occasional exacerbations - say one a year now instead of 3-4 although not have needed any short course antibiotics since I started taking it. I am still taking Azithromycin alternate days.

Fatigue is quite a big issue for me, days when I can do very little and need help although I do feel my lungs are deteriorating more slowly than they once were which is a small bonus.

Keep in touch and go well.

Pauline

clematis5932 profile image
clematis5932 in reply toPaulineHM

At first I really thought that my breathing had improved now II do not feel any improvement. Exacerbations have increased which has led to longer courses of steroids, four in fact since February.

Fatigue has long been an issue for me and if I am honest is the worst of the side effects. I also developed Epilepsy four years ago which the medication also has a lot of side effects. II shall keep going on Roflumilast hoping that in time it may improve my quality of life. x

Bingo88 profile image
Bingo88

Thanks for the information. Just hope we have the option of trying it here soon. Brian

Timberman profile image
Timberman

May be terrific news but COPD is not a disease but a group. So which disease does this address? And the phrase 'uncontrolled' seems a bit strange.

Timberman profile image
Timberman

I did a quick search. The vast majority of COPD patients can stop getting excited - this is about Asthma which is why the word controlled is important. It has no value for emphysema or bronchiectasis and thus for chronic bronchitis either. IF it does a better hiob than Salbutamol or that via nebulizing then it could be of huge value to those with asthma as the man compnent of their COPD.

PaulineHM profile image
PaulineHM

This drug is currently approved ( as you know ) for Asthma. Some patients and I am one of them have both conditions Asthma and COPD. This is known as Asthma COPD Overlap Syndrome or ACOS for short. I was diagnosed with it 20 years ago.

Given the two conditions exist together, it makes it less manageable with bacterial exacerbations which are often concurrent so the damage to the lungs is more extensive. It is know to be more of a challenge to manage and the mortality levels are higher. I have Type1 Respiratory failure for the past 8 years.

Of course when it is approved then it will be offered in a very targeted way to those who need it most- i.e those with Type 2 inflammation.

You might find this information from Sanofi helpful to read through.

sanofi.com/en/media-room/pr...

Go well.

Pauline

Not what you're looking for?

You may also like...

A New drug that treats COPD has been cleared by the US Food & Drug Admin.Anyone know anything about this drug?

WEDNESDAY, Dec. 18, 2013 (HealthDay News) -- A new inhaled drug to treat a serious lung condition...
Sohara profile image

New approved treatment for severe COPD

Nice have approved a tablet Roflimilast for people with severe COPD the drug eased systems that...
pegbl profile image

New quality standards for COPD care

Hi all, The National Institute for Care and Excellence (NICE), a national health care body that...

New drug trial

Novartis International AG ( NVS ) said the 64-week SPARK study results demonstrated that...
martin1945 profile image

Benefits of exercises for COPD

I want to refer you to an article on WEBMED about the vital benefits of exercises for COPD. Perha[s...
helingmic profile image

Moderation team

See all
moderator_AandLUK profile image
moderator_AandLUKAdministrator
AsthmaandLung profile image
AsthmaandLungAdministrator
Claire_ALUK profile image
Claire_ALUKAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.